France is Europe’s second-largest consumer of benzodiazepines – a class of sedatives that includes drugs like Valium and Xanax. Every year, nearly 10 million patients are prescribed these pills to treat anxiety and insomnia. While they are intended only for short-term use, treatments are often extended indefinitely, without proper supervision. Dependency sets in, affecting everyone from teenagers to elderly patients. FRANCE 24’s Olivia Bizot reports.
Source link
When a miracle pill becomes a trap: France's addiction to anti-anxiety medication
